Impact of the COVID-19 outbreak on cancer patient flow and management: experience from a large university hospital in Spain

por Manso, Luis, De Velasco, Guillermo, Paz-Ares, Luis
Publicado 2020

Three case reports: Temporal association between tyrosine-kinase inhibitor-induced hepatitis and immune checkpoint inhibitors in renal cell carcinoma

por Carretero-González, Alberto, Salamanca Santamaría, Javier, Castellano, Daniel, de Velasco, Guillermo
Publicado 2019

In Reply

por de Velasco, Guillermo, Culhane, Aedín C., Heng, Daniel Y.C., Signoretti, Sabina, Choueiri, Toni K.
Publicado 2017

Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma

por Carril-Ajuria, Lucía, Santos, María, Roldán-Romero, Juan María, Rodriguez-Antona, Cristina, de Velasco, Guillermo
Publicado 2019

Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis.

por Carretero-González, Alberto, Otero, Irene, Lora, David, Carril-Ajuria, Lucía, Castellano, Daniel, de Velasco, Guillermo
Publicado 2021

Comparative safety analysis of immunotherapy combined with chemotherapy versus monotherapy in solid tumors: a meta-analysis of randomized clinical trials

por Carretero-González, Alberto, Lora, David, Ghanem, Ismael, Otero, Irene, López, Flora, Castellano, Daniel, de Velasco, Guillermo
Publicado 2019

Immune Checkpoint Inhibitor Combination Therapy versus Sunitinib as First-Line Treatment for Favorable-IMDC-Risk Advanced Renal Cell Carcinoma Patients: A Meta-Analysis of Randomiz...

por Manneh, Ray, Lema, Mauricio, Carril-Ajuria, Lucía, Ibatá, Linda, Martínez, Susan, Castellano, Daniel, de Velasco, Guillermo
Publicado 2022

Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clini...

por Castellano, Daniel, Puente, Javier, de Velasco, Guillermo, Chirivella, Isabel, López-Criado, Pilar, Mohedano, Nicolás, Fernández, Ovidio, García-Carbonero, Icíar, González, María Belén, Grande, Enrique
Publicado 2014

Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trials

por Carretero-González, Alberto, Lora, David, Ghanem, Ismael, Zugazagoitia, Jon, Castellano, Daniel, Sepúlveda, Juan M., López-Martin, José A., Paz-Ares, Luis, de Velasco, Guillermo
Publicado 2018

The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials

por Carretero-González, Alberto, Lora, David, Martín Sobrino, Isabel, Sáez Sanz, Irene, Bourlon, María T., Anido Herranz, Urbano, Martínez Chanzá, Nieves, Castellano, Daniel, de Velasco, Guillermo
Publicado 2020

Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis

por Carretero-González, Alberto, Hergueta-Redondo, Marta, Sánchez-Redondo, Sara, Ximénez-Embún, Pilar, Manso Sánchez, Luis, Gil, Eva Ciruelos, Castellano, Daniel, de Velasco, Guillermo, Peinado, Héctor
Publicado 2022

A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial

por de Velasco, Guillermo, Carril-Ajuria, Lucia, Guerrero-Ramos, Felix, Alonso-Gordoa, Teresa, Rodríguez-Moreno, Juan F., Carretero, Alberto, Martin-Soberon, Maricruz, de la Rosa-Kehrmann, Federico, Castellano, Daniel
Publicado 2020

Addendum: A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial

por de Velasco, Guillermo, Carril-Ajuria, Lucia, Guerrero-Ramos, Felix, Alonso-Gordoa, Teresa, Rodríguez-Moreno, Juan F., Carretero, Alberto, Martin-Soberon, Maricruz, de la Rosa-Kehrmann, Federico, Castellano, Daniel
Publicado 2022

New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors

por Bamias, Aristotelis, Merseburger, Axel, Loriot, Yohann, James, Nicholas, Choy, Ernest, Castellano, Daniel, Lopez-Rios, F, Calabrò, Fabio, Kramer, Mario, de Velasco, Guillermo, Zakopoulou, Roubini, Tzannis, Kimon, Sternberg, Cora N
Publicado 2023

miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma

por Trilla-Fuertes, Lucía, Miranda, Natalia, Castellano, Daniel, López-Vacas, Rocío, Farfán Tello, Carlos A., de Velasco, Guillermo, Villacampa, Felipe, López-Camacho, Elena, Prado-Vázquez, Guillermo, Zapater-Moros, Andrea, Espinosa, Enrique, Fresno Vara, Juan Ángel, Pinto, Álvaro, Gámez-Pozo, Angelo
Publicado 2020

Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma

por de Velasco, Guillermo, Wankowicz, Stephanie A., Madison, Russell, Ali, Siraj M., Norton, Craig, Duquette, Audrey, Ross, Jeffrey S., Bossé, Dominick, Lalani, Aly-Khan A., Miller, Vincent A., Stephens, Philip J., Young, Lauren, Hakimi, A. Ari, Signoretti, Sabina, Pal, Sumanta K., Choueiri, Toni K.
Publicado 2018

Urothelial cancer proteomics provides both prognostic and functional information

por de Velasco, Guillermo, Trilla-Fuertes, Lucia, Gamez-Pozo, Angelo, Urbanowicz, Maria, Ruiz-Ares, Gustavo, Sepúlveda, Juan M., Prado-Vazquez, Guillermo, Arevalillo, Jorge M., Zapater-Moros, Andrea, Navarro, Hilario, Lopez-Vacas, Rocio, Manneh, Ray, Otero, Irene, Villacampa, Felipe, Paramio, Jesus M., Vara, Juan Angel Fresno, Castellano, Daniel
Publicado 2017

Clinical Applications of Molecular Biomarkers in Prostate Cancer

por Couñago, Felipe, López-Campos, Fernando, Díaz-Gavela, Ana Aurora, Almagro, Elena, Fenández-Pascual, Esaú, Henríquez, Iván, Lozano, Rebeca, Linares Espinós, Estefanía, Gómez-Iturriaga, Alfonso, de Velasco, Guillermo, Quintana Franco, Luis Miguel, Rodríguez-Melcón, Ignacio, López-Torrecilla, José, Spratt, Daniel E., Guerrero, Luis Leonardo, Martínez-Salamanca, Juan Ignacio, del Cerro, Elia
Publicado 2020

Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival

por Dudani, Shaan, de Velasco, Guillermo, Wells, J. Connor, Gan, Chun Loo, Donskov, Frede, Porta, Camillo, Fraccon, Anna, Pasini, Felice, Lee, Jae Lyun, Hansen, Aaron, Bjarnason, Georg A., Beuselinck, Benoit, Pal, Sumanta K., Yuasa, Takeshi, Kroeger, Nils, Kanesvaran, Ravindran, Reaume, M. Neil, Canil, Christina, Choueiri, Toni K., Heng, Daniel Y. C.
Publicado 2021

Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Rena...

por Gan, Chun Loo, Dudani, Shaan, Wells, J. Connor, Donskov, Frede, Pal, Sumanta K., Dizman, Nazli, Rathi, Nityam, Beuselinck, Benoit, Yan, Flora, Lalani, Aly‐Khan A., Hansen, Aaron, Szabados, Bernadett, de Velasco, Guillermo, Tran, Ben, Lee, Jae Lyun, Vaishampayan, Ulka N., Bjarnason, Georg A., Subasri, Mathushan, Choueiri, Toni K., Heng, Daniel Y. C.
Publicado 2021